amikacin has been researched along with azlocillin in 40 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 34 (85.00) | 18.7374 |
1990's | 3 (7.50) | 18.2507 |
2000's | 2 (5.00) | 29.6817 |
2010's | 1 (2.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Daschner, FD; Langmaack, H; Steffens, A | 1 |
Dudley, MN; Zinner, SH | 1 |
Blaser, J | 1 |
Bodunkova, LE; Ivanitskaia, LP; Kudinova, MK; Samoĭlova, LN; Viadro, MM | 1 |
Arnow, P; Edlin, B; Flaherty, JP; George, D; O'Keefe, P; Waitley, D; Weinstein, RA | 1 |
Benn, R; Benson, W; Date, L; Gibson, J; Iland, H; Joshua, DE; Kronenberg, H; Vincent, PC; Wilson, A; Young, GA | 1 |
Angelini, A; Betti, S; D'Antonio, D; Dell'Isola, M; di Girolamo, A; Dragani, A; Fioritoni, G; Iacone, A; Piccolomini, R | 1 |
Calandra, T; Gaya, H; Glauser, MP; Klastersky, J; Meunier, F; Zinner, SH | 1 |
Bayer, AS; Kim, KS | 1 |
Beaufils, F; Bingen, E; Guihaire, E; Lambert-Zechovsky, N; Mercier, JC; Nancy, C | 1 |
Bale, M; Howard, W; Koontz, F; Pfaller, M; Preston, T | 1 |
Blaser, J; Zinner, SH | 1 |
Bamberger, DM; Fasching, CE; Gerding, DN; Moody, JA; Peterson, LR | 1 |
Bébéar, C; Fourche, J; Mazaud, C; Mormede, M; Texier-Maugein, J | 1 |
Fasching, CE; Gerding, DN; Moody, JA; Peterson, LR | 2 |
Almela, M; Carreras, E; Grañena, A; Jiménez de Anta, MT; Marín, P; Rozman, C; Valls, A | 1 |
Fasching, CE; Gerding, DN; Peterson, LR | 1 |
Gaya, H; Glauser, MP; Klastersky, J; Schimpff, SC; Zinner, SH | 1 |
Johnson, DE; Thompson, B | 1 |
Antonioni, M; De Cristofaro, A; Mergoni, M; Stocchetti, N; Zuccoli, P | 1 |
Blaser, J; Dudley, M; Zinner, SH | 1 |
Klastersky, J | 1 |
Gilly, R; Grenier, B | 1 |
Bricaire, F; Bure, A; Humbert, G; Vachon, F; Vilde, JL | 1 |
Aznar, J; Iglesias, MC; Martin, E; Nogales, MC; Perea, EJ | 1 |
Bernard, C; Gaya, H; Klastersky, J; Ryff, JC; Zinner, SH | 1 |
Balischewski, B; Kiessig, R; Köditz, H; Thal, W | 1 |
Jacquillat, C; Khayat, D; Maral, J | 1 |
Boulton Jones, JM; Gribben, J; Leung, AC; Sleigh, JD | 1 |
Gerding, DN; Moody, JA; Peterson, LR | 1 |
Barry, AL; Gavan, TL; Jones, RN; Thornsberry, C | 1 |
Pickering, LK; Rutherford, I | 1 |
Baltch, AL; Conroy, JV; Hammer, MC; Matzkowitz, AJ; Smith, RP; Sutphen, NT | 1 |
Burghoffer, B; Daguet, GL; Petit, JC; Richard, G | 1 |
Shah, PM; Siegel, K; Stille, W | 1 |
Ferrer, NF; Hernández, ME; Ramos, MJ | 1 |
9 trial(s) available for amikacin and azlocillin
Article | Year |
---|---|
Gram-positive bacteraemia in granulocytopenic cancer patients.
Topics: Agranulocytosis; Amikacin; Azlocillin; Bacterial Infections; Ceftazidime; Drug Therapy, Combination; Gram-Positive Bacteria; Humans; Neoplasms; Prospective Studies; Randomized Controlled Trials as Topic; Sepsis | 1990 |
Multicenter, randomized trial of ciprofloxacin plus azlocillin versus ceftazidime plus amikacin for empiric treatment of febrile neutropenic patients.
Topics: Adult; Aged; Aged, 80 and over; Agranulocytosis; Amikacin; Azlocillin; Bacterial Infections; Ceftazidime; Ciprofloxacin; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Multicenter Studies as Topic; Neutropenia; Random Allocation | 1989 |
A randomised trial of empirical antibiotic therapy in febrile neutropenic patients with hematological disorders: ceftazidime versus azlocillin plus amikacin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Agranulocytosis; Amikacin; Azlocillin; Bacterial Infections; Ceftazidime; Drug Therapy, Combination; Female; Fever; Floxacillin; Hematologic Diseases; Humans; Male; Middle Aged; Neutropenia; Randomized Controlled Trials as Topic; Remission Induction; Therapeutic Equivalency | 1989 |
Evaluation of azlocillin-amikacin combination for empirical therapy of infection in febrile neutropenic patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Azlocillin; Bacterial Infections; Child; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Neutropenia | 1989 |
Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Azlocillin; Ceftazidime; Child; Child, Preschool; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Humans; Leukemia; Leukocyte Count; Male; Middle Aged; Neoplasms; Prognosis; Random Allocation; Regression Analysis; Sepsis | 1987 |
Prospective randomized comparison of three antibiotic regimens for empirical therapy of suspected bacteremic infection in febrile granulocytopenic patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Azlocillin; Cefotaxime; Child; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Kanamycin; Male; Middle Aged; Penicillins; Prospective Studies; Random Allocation; Regression Analysis; Sepsis; Ticarcillin | 1986 |
Azlocillin versus azlocillin plus amikacin in the treatment of severe infections in intensive care unit patients.
Topics: Adult; Aged; Amikacin; Azlocillin; Bacterial Infections; Critical Care; Cross Infection; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Random Allocation | 1987 |
In vitro and in vivo studies of three antibiotic combinations against gram-negative bacteria and Staphylococcus aureus.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Azlocillin; Cefotaxime; Enterobacteriaceae; Escherichia coli; Escherichia coli Infections; Humans; In Vitro Techniques; Klebsiella; Klebsiella Infections; Mice; Mice, Inbred BALB C; Penicillins; Pseudomonas aeruginosa; Serratia; Staphylococcus aureus | 1981 |
[Role of azlocillin in the treatment of immunocompromised patients. Results of the EORTC (European Organization for Research on the Treatment of Cancer) study)].
Topics: Agranulocytosis; Amikacin; Azlocillin; Bacterial Infections; Cefotaxime; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Neoplasms; Penicillins; Ticarcillin | 1984 |
31 other study(ies) available for amikacin and azlocillin
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
In vitro efficacy of Bay k 4999, a new ureido-penicillin, in combination with aminoglycosides against Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae and Proteus strains.
Topics: Amikacin; Aminoglycosides; Azlocillin; Drug Synergism; Escherichia coli; Gentamicins; Imidazolidines; Klebsiella pneumoniae; Netilmicin; Penicillin Resistance; Penicillins; Proteus; Pseudomonas aeruginosa; Sisomicin; Tobramycin | 1979 |
Single daily dosing of amikacin in an in-vitro model.
Topics: Amikacin; Azlocillin; Drug Resistance, Microbial; Drug Therapy, Combination; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 1991 |
Interactions of antimicrobial combinations in vitro: the relativity of synergism.
Topics: Amikacin; Azlocillin; Ceftazidime; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae; Escherichia coli; Imipenem; Klebsiella pneumoniae; Moxalactam; Netilmicin; Piperacillin; Pseudomonas aeruginosa; Staphylococcus aureus | 1990 |
[Combined chemotherapy of experimental infection in neutropenia].
Topics: Agranulocytosis; Amikacin; Animals; Azlocillin; Cefotaxime; Drug Synergism; Drug Therapy, Combination; Escherichia coli Infections; Immune Tolerance; Klebsiella Infections; Mice; Neutropenia; Opportunistic Infections; Pseudomonas Infections | 1989 |
In vivo efficacy of azlocillin and amikacin versus ciprofloxacin with and without amikacin in experimental right-sided endocarditis due to Pseudomonas aeruginosa.
Topics: Amikacin; Animals; Azlocillin; Ciprofloxacin; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Kanamycin; Penicillin Resistance; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines; Rabbits; Time Factors | 1986 |
[Value of bactericidal curves in the optimal selection of a beta-lactam-aminoglycoside combination on Pseudomonas aeruginosa. In vitro study of 40 strains of Pseudomonas aeruginosa isolated in pediatric intensive care units].
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Cefsulodin; Ceftazidime; Drug Therapy, Combination; Microbial Sensitivity Tests; Penicillin Resistance; Pseudomonas aeruginosa; Ticarcillin | 1986 |
In vitro inhibitory and bactericidal activity of cefpiramide and seven antipseudomonal agents against Pseudomonas aeruginosa.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Cefoperazone; Cefsulodin; Ceftazidime; Cephalosporins; Drug Combinations; Drug Synergism; Gentamicins; Humans; Imipenem; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Thienamycins; Time Factors; Tobramycin | 1986 |
In-vitro studies of antibiotic combinations with special emphasis on the evaluation of newly developed methods.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Ceftazidime; Drug Combinations; Drug Synergism; Escherichia coli; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Moxalactam; Netilmicin; Piperacillin; Pseudomonas aeruginosa; Staphylococcus aureus; Thienamycins | 1986 |
Ciprofloxacin, azlocillin, ceftizoxime and amikacin alone and in combination against gram-negative bacilli in an infected chamber model.
Topics: Amikacin; Animals; Azlocillin; Cefotaxime; Ceftizoxime; Ciprofloxacin; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Gram-Negative Bacteria; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Rabbits | 1986 |
[Bacteriostatic activity of azlocillin, gentamycin, amikacin singly or in combination on 200 strains of Pseudomonas aeruginosa].
Topics: Amikacin; Azlocillin; Drug Combinations; Drug Synergism; Gentamicins; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 1986 |
In vivo and in vitro activity of ciprofloxacin plus azlocillin against 12 streptococcal isolates in a neutropenic site model.
Topics: Amikacin; Animals; Azlocillin; Ciprofloxacin; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Enterococcus faecalis; Female; Gentamicins; Kinetics; Neutropenia; Penicillin G; Rabbits; Streptococcal Infections; Streptococcus; Streptococcus pneumoniae | 1987 |
[Microorganisms isolated in 54 patients receiving bone marrow transplants and evaluation of their sensitivity to antimicrobial agents].
Topics: Amikacin; Anti-Bacterial Agents; Azlocillin; Bacterial Infections; Bone Marrow Transplantation; Cefotaxime; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Penicillin Resistance | 1987 |
Treatment of ciprofloxacin- and ceftizoxime-induced resistant gram-negative bacilli.
Topics: Amikacin; Animals; Azlocillin; Bacterial Infections; Cefotaxime; Ceftizoxime; Ciprofloxacin; Drug Evaluation, Preclinical; Female; Gram-Negative Bacteria; Penicillin Resistance; Rabbits | 1987 |
Efficacy of single-agent therapy with azlocillin, ticarcillin, and amikacin and beta-lactam/amikacin combinations for treatment of Pseudomonas aeruginosa bacteremia in granulocytopenic rats.
Topics: Agranulocytosis; Amikacin; Animals; Azlocillin; Drug Therapy, Combination; Female; Kanamycin; Microbial Sensitivity Tests; Neutropenia; Penicillin Resistance; Penicillins; Pseudomonas Infections; Rats; Rats, Inbred Strains; Sepsis; Ticarcillin | 1986 |
In vitro models for the study of combination antibiotic therapy in neutropenic patients.
Topics: Agranulocytosis; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Bacterial Infections; Carbenicillin; Cefazolin; Cephalothin; Drug Therapy, Combination; Gentamicins; Humans; Models, Biological; Neutropenia; Pseudomonas Infections; Risk | 1986 |
Treatment of severe infections in patients with cancer. The role of new acyl-penicillins.
Topics: Amikacin; Azlocillin; Bacterial Infections; Drug Therapy, Combination; Humans; Mezlocillin; Neoplasms; Penicillins; Piperacillin | 1982 |
[Azlocillin treatment of Pseudomonas aeruginosa bronchopulmonary infections in children with cystic fibrosis].
Topics: Adolescent; Amikacin; Azlocillin; Child; Child, Preschool; Cystic Fibrosis; Drug Therapy, Combination; Female; Humans; Male; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Sputum | 1984 |
[Pseudomonas aeruginosa meningitis treated with azlocillin. 5 cases].
Topics: Adolescent; Adult; Aged; Amikacin; Azlocillin; Drug Therapy, Combination; Female; Humans; Male; Meningitis; Middle Aged; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 1984 |
Synergy between cefotaxime, cefsulodin, azlocillin, mezlocillin and aminoglycosides against carbenicillin resistant or sensitive Pseudomonas aeruginosa.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Carbenicillin; Cefotaxime; Cefsulodin; Cephalosporins; Dibekacin; Drug Synergism; Gentamicins; Mezlocillin; Penicillin Resistance; Penicillins; Pseudomonas aeruginosa; Sisomicin; Tobramycin | 1980 |
[Antibacterial activities of amicacin, azlocillin and cefotaxim in bronchial secretion and serum of children].
Topics: Amikacin; Anti-Infective Agents; Azlocillin; Bronchi; Cefotaxime; Child; Humans; Kanamycin; Penicillins | 1983 |
Comparison of azlocillin, ceftizoxime, cefoxitin, and amikacin alone and in combination against Pseudomonas aeruginosa in a neutropenic-site rabbit model.
Topics: Agranulocytosis; Amikacin; Animals; Anti-Bacterial Agents; Azlocillin; Cefotaxime; Cefoxitin; Ceftizoxime; Disease Models, Animal; Drug Combinations; Female; Hydrogen-Ion Concentration; Kanamycin; Microbial Sensitivity Tests; Neutropenia; Penicillins; Protein Binding; Pseudomonas Infections; Rabbits | 1984 |
Successful treatment of multiresistant pseudomonas peritonitis with combination of azlocillin and amikacin.
Topics: Amikacin; Azlocillin; Female; Humans; Kanamycin; Middle Aged; Penicillin Resistance; Penicillins; Peritonitis; Pseudomonas aeruginosa; Pseudomonas Infections | 1983 |
In vitro activities of ureidopenicillins alone and in combination with amikacin and three cephalosporin antibiotics.
Topics: Amikacin; Anti-Bacterial Agents; Azlocillin; Bacteria; Cephalosporins; Drug Interactions; Kanamycin; Mezlocillin; Microbial Sensitivity Tests; Penicillins; Pseudomonas aeruginosa | 1984 |
In vitro activity of mezlocillin and azlocillin compared with that of four other penicillins and two aminoglycosides.
Topics: Amikacin; Ampicillin; Azlocillin; Bacteria; Carbenicillin; Gentamicins; Kanamycin; Mezlocillin; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Ticarcillin | 1980 |
Effect of concentration and time upon inactivation of tobramycin, gentamicin, netilmicin and amikacin by azlocillin, carbenicillin, mecillinam, mezlocillin and piperacillin.
Topics: Amdinocillin; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Carbenicillin; Gentamicins; Mezlocillin; Netilmicin; Penicillins; Piperacillin; Time Factors; Tobramycin | 1981 |
In vitro comparison of N-formimidoyl thienamycin (MK0787) and Azlocillin with three aminoglycosides and ticarcillin against Pseudomonas aeruginosa.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Gentamicins; Imipenem; Lactams; Microbial Sensitivity Tests; Penicillins; Pseudomonas aeruginosa; Ticarcillin; Tobramycin | 1982 |
[Synergistic activity between ticarcillin, azlocillin, cefsulodin, ceftazidime and tobramycin or amikacin against Pseudomonas aeruginosa (author's transl)].
Topics: Amikacin; Anti-Bacterial Agents; Azlocillin; Cefsulodin; Ceftazidime; Cephalosporins; Drug Synergism; Penicillin Resistance; Penicillins; Pseudomonas aeruginosa; Ticarcillin; Tobramycin | 1982 |
[Clinical experience with non-specific broad-spectrum antibacterial chemotherapy (author's transl)].
Topics: Adult; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Bacterial Infections; Cefoxitin; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Middle Aged; Penicillins; Tobramycin | 1982 |
[Azlocillin plus amikacin: an alternative therapy for sepsis caused by resistant staphylococci?].
Topics: Amikacin; Anti-Bacterial Agents; Azlocillin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Microbial Sensitivity Tests; Models, Theoretical; Retrospective Studies; Sepsis; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus | 2004 |